Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Horng Chen, Mayo Clinic Identifier:
First received: August 31, 2012
Last updated: August 8, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)